| Market revenue in 2024 | USD 21.1 million |
| Market revenue in 2030 | USD 61.4 million |
| Growth rate | 19.5% (CAGR from 2025 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, NGS Commercial Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, DNAnexus, Qiagen NV, DNAstar, Pacific Biosciences of California Inc, Eurofins Scientific SE, Illumina Inc, PierianDx, Agilent Technologies Inc, Roche Holding AG, Alphabet Inc Class A, Thermo Fisher Scientific Inc, Golden Helix, Scigenom Labs, Genuity Science, Fabric Genomics (formerly Omicia), Congenica, Precigen |
In Spain, several NGS manufacturers are undertaking strategic distribution agreements with local Spanish distributors to increase accessibility of their NGS products. For instance, in May 2019, Agendia, Inc. entered into a strategic agreement with Spain-based Imegen for distribution of its Mamma Print and Blue Print breast cancer genomic tests in Spain.
Furthermore, GESMD is one of the end users of data analysis tools for NGS in Spain. It uses the tools for data analysis, including Variant Studio (Illumina), DNA nexus (DNA nexus, Santa Clara, CA, U.S.), Mi Seq Reporter (Illumina), Mi Seq Reporter (Illumina), Mi Seq Reporter (Illumina), and Sophia DDM (Sophia Genetics, Lausanne, Vaud, Switzerland).
Similarly, market players are innovating new solutions for end users in order to maintain their positions through product differentiation. For instance, in June 2021, Bio Bam introduced Omics Box 2.0 in the Spanish market as a bioinformatics solution. It is a data analysis platform for researchers to access biological information from NGS data.
Publish Date: Nov 10, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Alphabet Inc Class A | View profile | 180,895 | 1600 Amphitheatre Parkway, Mountain View, CA, United States, 94043 | www.abc.xyz |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Eurofins Scientific SE | View profile | 61,798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | www.eurofins.com |
| Pacific Biosciences of California Inc | View profile | 796 | 1305 O’Brien Drive, Menlo Park, CA, United States, 94025 | www.pacb.com |
| DNAnexus | View profile | 101-250 | Mountain View, California, United States, North America | dnanexus.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Next-generation Sequencing Data Analysis Market Outlook will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 64.45% in 2024.
Horizon Databook has segmented the Spain next-generation sequencing data analysis market based on services, ngs commercial software covering the revenue growth of each sub-segment from 2018 to 2030.
In Spain, several NGS manufacturers are undertaking strategic distribution agreements with local Spanish distributors to increase accessibility of their NGS products. For instance, in May 2019, Agendia, Inc. entered into a strategic agreement with Spain-based Imegen for distribution of its Mamma Print and Blue Print breast cancer genomic tests in Spain.
Furthermore, GESMD is one of the end users of data analysis tools for NGS in Spain. It uses the tools for data analysis, including Variant Studio (Illumina), DNA nexus (DNA nexus, Santa Clara, CA, U.S.), Mi Seq Reporter (Illumina), Mi Seq Reporter (Illumina), Mi Seq Reporter (Illumina), and Sophia DDM (Sophia Genetics, Lausanne, Vaud, Switzerland).
Similarly, market players are innovating new solutions for end users in order to maintain their positions through product differentiation. For instance, in June 2021, Bio Bam introduced Omics Box 2.0 in the Spanish market as a bioinformatics solution. It is a data analysis platform for researchers to access biological information from NGS data.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain Next-generation Sequencing Data Analysis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Spain Next-generation Sequencing Data Analysis Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
